Latest News about PRVB
Recent news which mentions PRVB
   Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
   
  
  
  November 03, 2022
  From Benzinga
 
   Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results
   
  
  
  November 03, 2022
  From Benzinga
 
   Crude Oil Down Over 1%; Lincoln National Shares Plunge
   
  
  
  November 03, 2022
  From Benzinga
 
   US Stocks Open Lower; Nasdaq Drops 100 Points
   
  
  
  November 03, 2022
  From Benzinga
 
   Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
   
  
  
  November 01, 2022
  From Benzinga
 
   These 2 Growth Stocks Have Potential Catalysts on the Way
   
  
  
  October 12, 2022
  From Motley Fool
 From Benzinga
 
   Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
   
  
  
  October 10, 2022
  From Benzinga
 From Benzinga
 
   Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
   
  
  
  October 07, 2022
  From Benzinga
 From Benzinga
 
   Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
   
  
  
  October 07, 2022
  From Benzinga
 From Benzinga
 
   Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
   
  
  
  October 06, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Intraday Session
   
  
  
  October 06, 2022
  From Benzinga
 
   Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
   
  
  
  October 06, 2022
  From Benzinga
 
   12 Health Care Stocks Moving In Thursday's Pre-Market Session
   
  
  
  October 06, 2022
  From Benzinga
 
   Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
   
  
  
  October 06, 2022
  From Benzinga
 
   Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
   
  
  
  September 20, 2022
  From Benzinga
 
   2 Under-the-Radar Biotech Stocks to Buy in 2022
   
  
  
  August 12, 2022
  From Motley Fool
 
   This Stock Could Soar by Nearly 300%, Says Wall Street
   
  
  
  July 26, 2022
  From Motley Fool
 
   Get in front of these three stock market sectors before they blossom into mainstream darlings
   
  
  
  July 22, 2022
  From MarketWatch
 From Benzinga
 From Benzinga
 From Benzinga
 
   U.S. FDA Extends Review By Three Months For Provention Bio's Type 1 Diabetes Candidate
   
  June 30, 2022
  Tickers 
   PRVB
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.